Detailed duties include: Performing molecular and cellular experiments on the mechanisms of cancer progression and therapy resistance, particularly in prostate, breast, myeloma, and rare cancers. Experiments will include molecular cloning of genetic aberrations identified through next-generation sequencing followed by expression and establishment of cell culture model systems. CRISPR technologies will be used to establish knockout and conditional knockout models. The applicant will learn how to generate next-generation sequencing libraries spanning a range of technologies, from cell-free DNA to ChIP-Seq.
This position is ideal for individuals who are interested in leading projects. The work has the potential to lead to discoveries that can directly translate into the clinic. This position will also co-ordinate research projects with other staff and undergraduate students.
Participate in Mi-ONCOSEQ CLIA clinical sequencing lab activities, nucleic acid extraction from blood, bone marrow, frozen tissue, buccal swabs, and FFPE, cell selection using antibody-conjugated magnetic beads, prepare samples through PCR and gel electrophoresis for sequencing, check the sample quality via bioanalyzer and QPCR, run the next-gen sequencing platform, validate the potential candidate genes by Sanger sequencing and QPCR, write internal research reports summarizing research activities, participate in weekly laboratory meetings, and interact as a team member with laboratory personnel. Write and develop CLIA SOPs, carry out high demand next generation sequencing procedures, independently run experiments and interpret results, help with manuscript writing and organizing data, and contribute to general lab management and CLIA clinical test compliance.